Glossary
A
- Active ingredient
- Adverse effect
- Agonist
- Allergenics
- Ames test
- Antagonist
- Approved drug
- Associated condition
- ATC codes
B
- Binding Strength
- Biodegradation
- Biotech drug
- Black box warning
- Blood brain barrier
- Boiling point
C
- Caco-2 permeable
- Carcinogenicity
- Carrier
- CAS Number
- Cell transplant therapies
- Chemical Formula
- Clinical trial
- Condition
- Contraindication
- CYP450 1A2 substrate ADMET Feature Prediction
- CYP450 2C19 inhibitor ADMET Feature Prediction
- CYP450 2C9 inhibitor ADMET Feature Prediction
- CYP450 2C9 substrate ADMET Feature Prediction
- CYP450 2D6 inhibitor ADMET Feature Prediction
- CYP450 2D6 substrate ADMET Feature Prediction
- CYP450 3A4 inhibitor ADMET Feature Prediction
- CYP450 3A4 substrate ADMET Feature Prediction
- CYP450 inhibitory promiscuity
- Cytochrome P-450 Interactions
D
- Dosage form
- Dosage route
- Drug
- Drug active moiety
- Drug Binding
- Drug Card
- Drug Group
- Drug Identification Number (DIN)
- Drug Indication
- Drug interaction
- Drug label
- Drug patent
- Drug Product
E
- Enzyme
- Ester prodrug
- Evidence level
- Evidence type
- Experimental drug
- Experimental property
F
- Food interaction
- Formulation Strength
G
- Gene therapies
H
- hERG inhibition (predictor I)
- hERG inhibition (predictor II)
- Human Intestinal Absorption
- Hydrophobicity
I
- ICD10
- Illicit drug
- Inactive ingredient
- InChI
- InChI key
- Inducer
- Inhibitor
- Investigational drug
- Isoelectric point
- IUPAC Name
J
K
L
- Lipinski's rule of five
- Log S
- LogP
M
- Management
- Mechanism of Action
- MedDRA
- Melting point
- Metabolic Reaction
- Metabolite
- Molecular Weight
N
- Narrow Therapeutic Index Drug
- National Drug Code (NDC)
- Nucleic acid based therapies
- Nutraceutical drug
O
- Off label
P
- P-glycoprotein inhibitor I ADMET Feature Prediction
- P-glycoprotein inhibitor II ADMET Feature Prediction
- P-glycoprotein substrate ADMET Feature Prediction
- Pharmacological Action
- pKa
- Polypeptide
- Predicted ADMET features
- Predicted Bioavailability
- Predicted property
- Product Concept
- Protein based therapies
Q
R
- Radioactivity
- Rat acute toxicity ADMET Feature Prediction
- Reaction Type
- Renal organic cation transporter ADMET Feature Prediction
S
- Salt
- Severity
- Small Molecule Drug
- SMILES
- SNP
- Substrate
T
- Target
- Transporter
U
V
- Vaccines
- Vet approved drug
W
- Water solubility
- Withdrawn drug
X
Y
Z
- Field Descriptions
- FAQ's
- Release Notes
Documentation
- CSV Format
- JSON Format
- XML Format
Documentation
- Clinical API
- Scientific API
Nucleic acid based therapies
In DrugBank, biotech drugs are subcategorized according to their intrinsic properties. The nucleic acid based therapy subcategory represents modified and unmodified nucleotide sequences shown to present pharmacological activity by acting in targets other than DNA and genetic constituents.
